Manganese-enhanced magnetic resonance imaging (MEMRI) enables tract tracing to follow neural pathways through axonal transport. However, the method is problematic because of the high local concentrations of Mn 2+ involved. We developed a tetrananogel containing a dextran-manganese complex (Dex-Mn-Gel) and applied this nanogel to rats. MnCl 2 (n = 5), Dex-Mn-Gel (n = 5), or saline control (n = 3) was injected into the left knee joint of the rats (n = 13). Inflammation and tissue alterations in the knee joint were also evaluated histologically. T1-weighted images were obtained on a 7 T MRI system 24 hours after the administration and compared across groups. The sciatic nerve in both legs and the surrounding musculature were used as regions of interest (ROI). No swelling was found in the knee joint infused with Dex-
such pain becomes chronic, and treatment for these conditions has not been clearly established. The stimulation of local nociceptors is transmitted through peripheral nerves, such as the sciatic nerves, up the spine to the brain where stimuli are perceived as pain. The elucidation of pain pathways in animal models has primarily focused on the use of immunohistological methods with nerve tracers such as FluoroGold. 1, 2 Several studies have utilized retrograde transport of FluoroGold in rats to show that sensory fibers from the T12 to L6 dorsal root ganglia (DRGs) innervate to the L5 to L6 intervertebral disc 1 and fibers from L4 DRGs extend to the knee joint. 2 However, a visualization method for these pathways in living animals has yet to be established.
If nerve tract tracing could be realized in vivo, and if pain transmission pathways could be visualized and analyzed in a minimally invasive manner, then, we will have gained a powerful index for the diagnosis and treatment of chronic pain, such as selective nerve root infiltration.
Recent improvement of magnetic resonance imaging (MRI)
devices, such as multichannel detection and improved pulse sequences, has allowed high resolution three-dimensional (3D) imaging with a shorter scanning time. Evaluation of peripheral nerve function or anatomy using MRI has been described, including blood-oxygen-level dependent (BOLD)-based functional MRI (fMRI) in the brain 3 and spinal cord, 4 and diffusion tensor imaging of the spine and peripheral nerves. 5 However, fMRI lacks spatial resolution and relies on the secondary response of blood flow, and diffusion tensorbased tract estimation cannot identify the nerve endings and the direction of the axonal transport microscopically. Manganese is an effective contrast agent that shortens longitudinal relaxation time (T1) and enhances the positive signal in T1-weighted images. When Mn 2+ is administered either locally or systemically, axonal transport can be followed or visualized through tract tracing (manganeseenhanced MRI: MEMRI) in the periphery 6, 7 and in the brain. 8, 9 MEMRI can be classified three types such as activity-induced MEMRI (AIM MRI) with blood-brain barrier disruption, 10 tract tracing with local administration, 6, 7 and neuroarchitectural/functional MEMRI with systemic administration. 11 In tract tracing 6, 7 involves subcutaneous or local administration of Mn that is transported through axonal transport allowing visualization of nerve tracts in the peripheral nerves and inside the brain. However, no papers have reported any success in a noninvasive trace of the sciatic nerve pathway.
However, most previous reports of MEMRI are confined to limited pathways: for example, through nasal mucosa for olfactory nerve tracing, or intraocular administration for optic nerve tracing, and few reports cover sciatic nerve tracing. 12, 13 To trace nerve tracts, MEMRI requires high local concentrations of MnCl 2 (100-4000 mM) to obtain sufficient contrast. These concentrations of MnCl 2 , however, are toxic to the local administration site 14 and the large difference in ion concentrations leads to serious swelling, particularly in tissue where it can diffuse, such as in muscle. Therefore, tract tracing using MEMRI has been applied in limited "isolated" areas, such as the ophthalmic or nasal cavities, where structures allow an "endogenous controlledrelease" of the contrast agent into the nerve endings. 15 We hypothesized that a tetrananogel containing a dextran- 
| METHODS
All protocols for animal procedures were reviewed and approved by the animal care and use committee of the National Institute of Radiological Sciences, Chiba-City, Japan, and followed the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals.
| Intra-articular manganese injection
Thirteen 6-week-old Sprague Dawley (SD) rats (body weight:
250-300 g, Japan SLC, Tokyo, Japan) were used. Contrast agents (MnCl 2 or Dex-Mn-Gel) were injected into the left knee joints of these rats under isoflurane inhalation anesthesia (1.5%-2.0%, Escain, Mylan, Tokyo, Japan). The contrast agent was injected through the patellar ligament using a 27-gauge needle with the leg flexed at a 90 angle at the knee. A group administered MnCl 2 (100 mM, 50 μL, n = 5), a group administered Dex-Mn-Gel (100 mM, 50 μL, n = 5), and a vehicle control group (n = 3) were compared. The MnCl 2 was dissolved in water and adjusted iso-osmotically using saline. 6 After the administration, the local injected area was confirmed using MRI. The knee joint image was enhanced 24 hours after administration of MnCl 2 into the joint capsule ( Figure 1A ).
| Manganese-enhanced MRI
T1-weighted images were obtained using 7 T MRI 24 hours after contrast agent injection. Rats were anesthetized using isoflurane (1.5%- 
| Preparation of the PEG-Ac monomer, DAB-Ac monomer, and Dex-Mn
Tetra-poly(ethyl glycol)-amine (Sunbright PTE-050PA; Mn, 5328 g/mol) was purchased from NOF Corporation (Tokyo, Japan). 
| Preparation of the nanogels containing Dex-Mn complex
Tetrananogels containing Dex-Mn-DOTA 15 were prepared using a modified method for nanogels containing proteins. 17, 19 The gel material, PEG-Ac, was synthesized by condensation reactions between tetra-PEG-amine and acryloyl chloride. The reacted product was precipitated in diethyl ether on ice, and the suspension was filtered, then dialyzed to purify the PEG-Ac. The structure of PEG-Ac was confirmed by 1 H NMR. 16 A mixture of 200 μL of 100 mg/mL the PEG-Ac, 50 μL of 400 mM (Mn   2+ ) Dex-Mn, 50 μL of 16 mg/mL DAB-Ac, 50 μL of 2 mg/mL of rhodamine, 25 μL of 0.1 mM APS, and 25 μL of 0.1 mM TEMED was stirred for 20 minutes at room temperature. The 3D polymer mesh structure of the gel entraps the Dex-Mn. After the reaction, the products were recovered using a Vivaspin 6 concentrator with a MWCO of 30 000 (Sartorius, Germany) at 6000 g for 15 minutes at 4 C.
Water was added to adjust gels to a final concentration of 100 mM Mn 2+ in gel solution.
| Properties of the nanogels
The nanogel containing concentrates were analyzed using a dynamic light scattering (DLS) system (Zetasizer Nano ZS, Malvern, Westborough, Massachusetts). Concentrated nanogel solutions containing Dex-Mn were stored. After 1 day, nanogel solutions were reconcentrated using a Vivaspin 6 concentrator with a MWCO of F I G U R E 1 Sagittal magnetic resonance images of the knee joint (A), axial images of the entire pelvis and both legs (B), and an enlarged picture of the sciatic nerve in the vicinity of the pelvic bone (C) after administering MnCl 2. The knee joint was enhanced at 24 hours after MnCl 2 administration into the joint capsule. The arrow indicates the contrast effect in the knee joint (A). Ant indicates anterior and Post indicate posterior. The sciatic nerve in the transaxial T1-weighted image (red circle) and surrounding muscle (white circle) were set as regions of interest (ROI). The normalized signal intensity ratio was calculated as the intensity of the sciatic nerve divided by the intensity in the muscle (C) 30 000. The relaxivities of the concentrate and filtrate were measured on a 1 T-MRI system (ICON, Bruker-Biospin) with a solenoid coil.
| Histopathology of the knee joint
The soft tissues around each side of the joint and cartilage including the synovium and capsule were resected under deep anesthesia.
Thereafter, the animal was euthanized. The resected limbs were cut at midfemur and midtibia and immersed in buffered paraformaldehyde fixative at 4 C for 1 week. The specimens were demineralized by K-CX (Falma, Tokyo, Japan) for 24 hours and the formalin fixedparaffin embedded tissue sections were prepared using standard histological techniques. Tissue sections were stained using hematoxylin and eosin (HE), and assessed by light microscopy. 
| Statistical analysis
Statistical analyses were performed using by SAS for Windows (Ver.
9.4, SAS Institute Inc., Cary, North Carolina). An Analysis of variance (ANOVA) followed by a post hoc test using the Bonferroni method was used to compare parameters between each group; P < .05 was considered significant. All data are expressed as the mean ± SD.
3 | RESULTS
| Toxicity of Mn 2+ in the knee joint capsule and its suppression
To achieve minimally invasive MEMRI tract tracing of the sciatic nerve, the Dex-Mn-Gel was prepared as a 120 nm nanogel, which was measured by DLS, and injected into the knee joint capsule. The knee joint showed swelling on the side administered 100 mM MnCl 2 ( Figure 2C ). In contrast, there was no difference between the side administered Dex-Mn-Gel and the normal side ( Figure 2B ). For the evaluation of swelling, we calculated the diameter ratio of the knee joint as the administered/normal side in the two-dimensional (2D) horizontal images. The diameter ratio of swelling in the knee in the MnCl 2 group was 1.5, which was a significant increase compared to the control (1.0) and Dex-Mn-Gel (1.1) groups (P < .05). WBC infiltration at the knee joint was also evaluated using H&E staining . WBC counts in the group administered MnCl 2 were approximately 10-fold higher than in the controls and this difference was significant (P < .001). By contrast, WBC counts in the group administered Dex-Mn-Gel were half that of the MnCl 2 group and were significantly less than in the group administered MnCl 2 (P < .001) ( Figure 3B ).
We designed and prepared Dex-Mn-Gel, which encapsulated (Table 1) .
| Manganese enhancement of the sciatic nerve tract
We evaluated MRI contrast enhancement of the sciatic nerve after (contralateral sides). In the treated leg, the sciatic nerve showed significantly higher contrast after MnCl 2 (P < .001) and Dex-Mn-Gel (P < .01) administration than untreated controls ( Figure 6) . Surprisingly, a small enhancement in the non-injected leg was also observed both in the MnCl 2 and Dex-MnGel treated rats ( Figure 6 ). We also performed a longitudinal measurement (n = 1) after MnCl 2 administration into the joint capsule. Figure 7 showed normalized signal ratio which was normalized to the signal intensity at 0 hour. There was little signal increase in either the ipsilateral or contralateral sciatic nerves 1 to 4 hours after MnCl 2 administration, and the signal in the ipsilateral side (1.147) increased higher than in the contralateral side (1.061) 24 hours after MnCl 2 administration, suggesting that the blood flow route is not a predominant contributor to contralateral side enhancement. 
| DISCUSSION

| Sciatic nerve tract tracing
MEMRI has been studied in a model of sciatic nerve injury in rats using local injection of MnCl 2 into the sciatic nerve 12 or peritoneum. 13 MnCl 2 administered into the sciatic nerve behaves as a retrograde , which correlated with the development of allodynia, was shown in a model of neuropathic pain. 13 To the best our knowledge, until now there has been no previous study that has visualized the tract of the sciatic nerve from the knee joint using an MRI tracer.
| Potential benefits and issues with Dex-MnGel use
There is currently just one Mn . 22 In future research, an optimized chelate for Mn 2+ with the Dex-Gel will isolate the nerve tract clearly and provide better contrast.
Advances in molecular biology methods have led to reporting of various mechanisms for the transmission of pain in musculoskeletal sensory pathways, but the mechanism underlying chronic musculoskeletal pain has yet to be fully elucidated, and treatment policies
have not yet been clearly established. Dex-Mn-Gel-based MEMRI will not only contribute to visualize the neural pathways and function but may also suggest treatment strategies for pain through the quantitative manganese transfer index. 23 In future studies, we will aim to further improve the safety of this method, evaluate toxicity, conduct 3D observation methods including the spinal cord, and apply our methods to various animal models of chronic musculoskeletal pain, such as models of nerve injury and knee joint injury, to advance the clinical potential of these methods.
In summary, we successfully visualized the sciatic nerve pathway in rats with MEMRI using a minimally invasive Dex-Mn-Gel-based method. Contrast-enhanced sciatic nerves were observed after administering the gel into knee joints. The 3D polymer mesh structure 
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